Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,369.00 at Robert W. Baird

Mettler-Toledo International (NYSE:MTD) had its price target boosted by Robert W. Baird from $1,362.00 to $1,369.00 in a research note released on Monday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical instruments supplier’s stock.

Several other equities analysts have also commented on MTD. Evercore ISI upgraded shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and upped their price target for the stock from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research report on Friday, December 13th. They issued a “peer perform” rating for the company. Citigroup raised Mettler-Toledo International from a “sell” rating to a “neutral” rating and lifted their price target for the company from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Stifel Nicolaus decreased their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Finally, Wells Fargo & Company lowered their target price on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $1,368.00.

Mettler-Toledo International Stock Down 3.6 %

Shares of NYSE:MTD opened at $1,339.46 on Monday. The firm has a 50-day simple moving average of $1,278.92 and a 200 day simple moving average of $1,342.95. Mettler-Toledo International has a fifty-two week low of $1,133.46 and a fifty-two week high of $1,546.93. The company has a market cap of $28.26 billion, a PE ratio of 33.05, a P/E/G ratio of 4.80 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 564.51% and a net margin of 22.29%. As a group, research analysts forecast that Mettler-Toledo International will post 41.94 EPS for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In related news, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the sale, the insider now directly owns 6 shares in the company, valued at approximately $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 1.94% of the company’s stock.

Institutional Investors Weigh In On Mettler-Toledo International

A number of institutional investors and hedge funds have recently modified their holdings of the stock. State Street Corp raised its position in shares of Mettler-Toledo International by 1.0% during the third quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock worth $1,431,693,000 after purchasing an additional 9,009 shares during the period. Geode Capital Management LLC raised its holdings in Mettler-Toledo International by 0.8% during the 3rd quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock worth $818,906,000 after buying an additional 4,166 shares during the period. Principal Financial Group Inc. raised its holdings in Mettler-Toledo International by 13.9% during the 4th quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock worth $335,977,000 after buying an additional 33,456 shares during the period. Barclays PLC lifted its stake in Mettler-Toledo International by 8.3% during the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after buying an additional 19,609 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after buying an additional 28,478 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.